These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 1996512)

  • 1. Anxiety and substance use disorders: a primer for primary care physicians.
    Landry MJ; Smith DE; McDuff D; Baughman OL
    J Am Board Fam Pract; 1991; 4(1):47-53. PubMed ID: 1996512
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The differential diagnosis of anxiety. Psychiatric and medical disorders.
    Cameron OG
    Psychiatr Clin North Am; 1985 Mar; 8(1):3-23. PubMed ID: 3887337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anxiety, depression, and substance use disorders: diagnosis, treatment, and prescribing practices.
    Landry MJ; Smith DE; Steinberg JR
    J Psychoactive Drugs; 1991; 23(4):397-416. PubMed ID: 1813612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anxiety and substance use disorders: the treatment of high-risk patients.
    Landry MJ; Smith DE; McDuff DR; Baughman OL
    J Am Board Fam Pract; 1991; 4(6):447-56. PubMed ID: 1767697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of the diagnostic criteria for psychosomatic research in substance use disorder patients.
    Tossani E; Ricci Garotti MG; Cosci F
    Psychother Psychosom; 2013; 82(3):195-6. PubMed ID: 23549064
    [No Abstract]   [Full Text] [Related]  

  • 6. Somatoform and substance use disorders.
    Hasin D; Katz H
    Psychosom Med; 2007 Dec; 69(9):870-5. PubMed ID: 18040097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anxiety disorders moderate the association between externalizing problems and substance use disorders: data from the National Comorbidity Survey-Revised.
    Hofmann SG; Richey JA; Kashdan TB; McKnight PE
    J Anxiety Disord; 2009 May; 23(4):529-34. PubMed ID: 19059752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinguishing symptoms of ADHD from other psychiatric disorders in the adult primary care setting.
    Montano CB; Weisler R
    Postgrad Med; 2011 May; 123(3):88-98. PubMed ID: 21566419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of substance use disorder on the clinical presentation of anxiety and depression in an outpatient psychiatric clinic.
    Tsuang D; Cowley D; Ries R; Dunner DL; Roy-Byrne PP
    J Clin Psychiatry; 1995 Dec; 56(12):549-55. PubMed ID: 8530330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Diagnosis and assessment of anxiety disorders].
    Günther E
    Praxis (Bern 1994); 1998 May; 87(21):731-4. PubMed ID: 9643095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comorbidity of anxiety and depression: epidemiologic perspectives].
    Lépine JP
    Encephale; 1994 Dec; 20 Spec No 4():683-92. PubMed ID: 7895636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. "Secondary" and drug-induced mood, anxiety, psychotic, catatonic, and personality disorders: a review of the literature.
    Popkin MK; Tucker GJ
    J Neuropsychiatry Clin Neurosci; 1992; 4(4):369-85. PubMed ID: 1422165
    [No Abstract]   [Full Text] [Related]  

  • 13. A population-based analysis of distinguishers of bipolar disorder from major depressive disorder.
    Schaffer A; Cairney J; Veldhuizen S; Kurdyak P; Cheung A; Levitt A
    J Affect Disord; 2010 Sep; 125(1-3):103-10. PubMed ID: 20223522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of co-occurring mood and anxiety disorders among substance-abusing youth.
    Lubman DI; Allen NB; Rogers N; Cementon E; Bonomo Y
    J Affect Disord; 2007 Nov; 103(1-3):105-12. PubMed ID: 17291589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and distinct correlates of anxiety, substance, and combined comorbidity in a multi-site public sector sample with bipolar disorder.
    Bauer MS; Altshuler L; Evans DR; Beresford T; Williford WO; Hauger R;
    J Affect Disord; 2005 Apr; 85(3):301-15. PubMed ID: 15780700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Psychiatrically relevant side effects of non-psychopharmacological pharmacotherapy].
    Kasper S; Jung B
    Nervenarzt; 1995 Sep; 66(9):649-61. PubMed ID: 7477602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anxiety and psychoactive substance use disorder comorbidity in anorexia nervosa or depression.
    Jordan J; Joyce PR; Carter FA; Horn J; McIntosh VV; Luty SE; McKenzie JM; Mulder RT; Bulik CM
    Int J Eat Disord; 2003 Sep; 34(2):211-9. PubMed ID: 12898557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reasons for substance use and vulnerability factors in patients with substance use disorder and anxiety or mood disorders.
    Bizzarri JV; Rucci P; Sbrana A; Gonnelli C; Massei GJ; Ravani L; Girelli M; Dell'osso L; Cassano GB
    Addict Behav; 2007 Feb; 32(2):384-91. PubMed ID: 16797139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Depression, anxiety, and somatoform disorders: vague or distinct categories in primary care? Results from a large cross-sectional study.
    Hanel G; Henningsen P; Herzog W; Sauer N; Schaefert R; Szecsenyi J; Löwe B
    J Psychosom Res; 2009 Sep; 67(3):189-97. PubMed ID: 19686874
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Change in accuracy of recognizing psychiatric disorders by non-psychiatric physicians: five-year data from a psychiatric consultation-liaison service.
    Su JA; Tsai CS; Hung TH; Chou SY
    Psychiatry Clin Neurosci; 2011 Dec; 65(7):618-23. PubMed ID: 22176280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.